Roche (RHHBY) expects an increase in Group sales in the mid single digit range. Core earnings per share are targeted to develop in the high single digit range. Roche expects to further increase its dividend in Swiss francs.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RHHBY:
- Roche receives CE Mark for Elecsys pTau181
- Roche pauses shipments of Elevidys outside the U.S., Bloomberg says
- Roche announces European Commission approved Itovebi
- AstraZeneca (AZN) Commits to $50B U.S. Investment as Tariff Threat Looms
- Roche announces ALIENTO trial meets, ARNASA study misses primary endpoint